Search Results - "Serlenga, L."

Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: a population based study by Zoccolella, S, Beghi, E, Palagano, G, Fraddosio, A, Guerra, V, Samarelli, V, Lepore, V, Simone, I L, Lamberti, P, Serlenga, L, Logroscino, G

“…Objective:To measure survivorship and predictors of prognosis of amyotrophic lateral sclerosis (ALS).Methods:Incident cases, diagnosed in the 1998–1999 period…”
Get full text

Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis by Girolamo, F., Lia, A., Amati, A., Strippoli, M., Coppola, C., Virgintino, D., Roncali, L., Toscano, A., Serlenga, L., Trojano, M.

“…Aims Sporadic inclusion body myositis (s‐IBM) is characterized by rimmed vacuole formation and misfolded protein accumulation. Intracellular protein aggregates…”
Get full text

Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis by ZOCCOLELLA, S, SIMONE, I. L, LAMBERTI, P, SAMARELLI, V, TORTELLI, R, SERLENGA, L, LOGROSCINO, G

“…Both in vitro and in vivo studies indicate that homocysteine (Hcy) may be directly involved in the damage of motor neurons and in several pathways implicated…”
Get full text

Incidence of amyotrophic lateral sclerosis in southern Italy: a population based study by Logroscino, G, Beghi, E, Zoccolella, S, Palagano, R, Fraddosio, A, Simone, I L, Lamberti, P, Lepore, V, Serlenga, L

“…Background: While the incidence of amyotrophic lateral sclerosis (ALS) is similar across the world (range, 1.0 to 2.5/100 000), a latitude gradient from north…”
Get full text

Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy by Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Guerra, V., Samarelli, V., Lepore, V., Simone, I. L., Lamberti, P., Serlenga, L., Logroscino, G.

“…Riluzole is to date the only treatment that prolongs amyotrophic lateral sclerosis (ALS) survival. However, results on the efficacy of riluzole in…”
Get full text

Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy by Zoccolella, S., Beghi, E., Palagano, G., Fraddosio, A., Samarelli, V., Lamberti, P., Lepore, V., Serlenga, L., Logroscino, G.

“…Amyotrophic lateral sclerosis (ALS) diagnostic criteria are used to select patients for clinical trials based on different levels of diagnostic certainty,…”
Get full text

Classification of amyotrophic lateral sclerosis cases at presentation in epidemiological studies by Zoccolella, S, Beghi, E, Serlenga, L, Logroscino, G

“…Amyotrophic lateral sclerosis (ALS) diagnosis is based exclusively on clinical grounds because of the absence of biological markers and of specific…”
Get full text

Cerebellar ataxia as atypical manifestation of the 3243A>G MELAS mutation by Petruzzella, V, Zoccolella, S, Amati, A, Torraco, A, Lamberti, P, Carnicella, F, Serlenga, L, Papa, S

Get full text

Spinocerebellar ataxia type 2 in southern Italy : a clinical and molecular study of 30 families by FILLA, A, DE MICHELE, G, SCALA, R, COPPOLA, G, CARUSO, G, COCOZZA, S, SANTORO, L, CALABRESE, O, CASTALDO, I, GIUFFRIDA, S, RESTIVO, D, SERLENGA, L, CONDORELLI, D. F, BONUCCELLI, U

“…Autosomal dominant cerebellar ataxia type I is the most common form of dominant ataxia. A genetic heterogeneity has been identified with five different loci…”
Get full text

A randomized controlled trial of recombinant interferon beta-1a in ALS by BEGHI, E, CHIO, A, TONALI, P, INGHILLERI, M, MAZZINI, L, MICHELI, A, MORA, G, POLONI, M, RIVA, R, SERLENGA, L, TESTA, D

Get full text

ALS-plus: 5 cases of concomitant amyotrophic lateral sclerosis and parkinsonism by Zoccolella, S, Palagano, G, Fraddosio, A, Russo, I, Ferrannini, E, Serlenga, L, Maggio, F, Lamberti, S, Iliceto, G

“…According to El Escorial criteria, amyotrophic lateral sclerosis (ALS), combined with other neurologic disorders, such as dementia and parkinsonism, is defined…”
Get full text

A case of concomitant amyotrophic lateral sclerosis and HIV infection by Zoccolella, S., Carbonara, S., Minerva, D., Palagano, G., Bruno, F., Ferrannini, E., Iliceto, G., Serlenga, L., Lamberti, P.

Get full text

Gravity models of intra-EU trade: application of the CCEP-HT estimation in heterogeneous panels with unobserved common time-specific factors by Serlenga, Laura, Shin, Yongcheol

“…We follow recent developments of panel data studies and allow for the existence of both observed and unobserved common factors where their individual responses…”
Get full text

Mitochondrial disease mimicking polymyositis: a case report by Corrado, A, Cantatore, F P, Serlenga, L, Amati, A, Petruzzella, V, Lapadula, G

“…The authors report on a 34-year-old woman who had developed severe weakness and reduction in grip strength in both upper and lower limbs. Laboratory blood…”
Get full text

Short-latency median nerve somatosensory evoked potentials in three cases of parkinsonism and dopa responsive dystonia by Margari, L, de Mari, M, Lamberti, P, Iliceto, G, Serlenga, L, Perniola, T, Rossini, P M, Ferrari, E

“…We studied somatosensory evoked potentials after median nerve stimulation in a sporadic case of dopa responsive dystonia and in two brothers with different…”
Get more information

Schwartz-Jampel syndrome with autosomal-dominant inheritance by Ferrannini, E, Perniola, T, Krajewska, G, Serlenga, L, Trizio, M

“…A 4-year follow-up study of 2 brothers affected by Schwartz-Jampel syndrome is reported. The children, aged 16 and 7 years, respectively, showed the clinical…”
Get more information

SHORT COMMUNICATION: Signs and symptoms at diagnosis of amyotrophic lateral sclerosis: a population-based study in southern Italy by Zoccolella, S, Beghi, E, Palagano, G, Fraddosio, A, Samarelli, V, Lamberti, P, Lepore, V, Serlenga, L, Logroscino, G

“…Amyotrophic lateral sclerosis (ALS) diagnostic criteria are used to select patients for clinical trials based on different levels of diagnostic certainty,…”
Get full text

G.P.1 08 Phenotype–genotype correlation in two families with muscle phosphofructokinase deficiency by Toscano, A., Bruno, C., Musumeci, O., Rodolico, C., Cassandrini, D., Aguennouz, M., Serlenga, L., Zoccolella, S., Amati, A., Vita, G.

Get full text

Heterogeneity and cross section dependence in panel data models: theory and applications by Baltagi, B H, Pesaran, M Hashem, Choi, I, Chue, T K, Kapetanios, G, Bresson, G, Pirotte, A, Serlenga, L, Shin, Y, Moon, H R, Perron, B, Fachin, S, Hsiao, C, Shen, Y, Wang, B, Weeks, G

Get full text

Freezing gait in Parkinson's disease by Lamberti, P, Armenise, S, Castaldo, V, de Mari, M, Iliceto, G, Tronci, P, Serlenga, L

“…Freezing is a well-known problem in Parkinson's disease (PD) and is characterized by an abrupt difficulty in starting or continuing rhythmic and repetitive…”
Get more information